Comparison of immunogenicity of two yeast-derived recombinant hepatitis B vaccines

A comparison was conducted of the immunogenicity of two yeast recombinant vaccines with different doses [10 μg Recombivax-HB (Merck Sharpe & Dohme Ltd) vs. 20 μg Engerix-B (Smith Kline Biologicals)]. This was conducted as a randomized, blinded study in healthy preclinical medical students, negat...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vaccine 1991-02, Vol.9 (2), p.97-100
Hauptverfasser:	Hammond, G.W., Parker, J., Mimms, L., Tate, R., Sekla, L., Minuk, G.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult antibodies Biological and medical sciences Evaluation Studies as Topic Female Fundamental and applied biological sciences. Psychology Hepatitis B - prevention & control Hepatitis B Antibodies - biosynthesis Hepatitis B vaccine Hepatitis B Vaccines Hepatitis B virus - immunology Humans immunogenicity Male Microbiology radioimmunoassay recombinant vaccine recombinants Urticaria - etiology vaccines Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies Vaccines, Synthetic - adverse effects Vaccines, Synthetic - immunology Viral Hepatitis Vaccines - adverse effects Viral Hepatitis Vaccines - genetics Viral Hepatitis Vaccines - immunology Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!